Finanzen von Avanos Medical Inc (AVNS)AVNSAvanos Medical Inc

Avanos Medical Inc (AVNS) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Digestive Health, accounting for 68.8% of total sales, equivalent to $124.00M. Another important revenue stream is Pain Management. Understanding this composition is critical for investors evaluating how AVNS navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, Avanos Medical Inc maintains a gross margin of 51.70%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 6.37%, while the net margin is 2.80%. These profitability ratios, combined with a Return on Equity (ROE) of -9.18%, provide a clear picture of how effectively AVNS converts its operational activities into shareholder value.

In the context of the broader market, AVNS competes directly with industry leaders such as DRTS and AORT. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, AVNS's gross margin of 51.70% stands against DRTS's N/A and AORT's 64.03%. Such benchmarking helps identify whether Avanos Medical Inc is trading at a premium or discount relative to its financial performance.